Canadè V, Catapano F, Muraca L, Cosentino A
Divisione di Medicina Generale, Ospedale di Corigliano Calabro, Cosenza.
Minerva Med. 1991 Mar;82(3):111-4.
In order to assess the efficacy of Nimodipine against a polymorphous pathology, such as chronic cerebrovascular insufficiency, the authors studied 96 subjects affected by chronic cerebrovascular diseases aged between 65 and 85 years old. The various symptoms were evaluated individually using tests and subjects were then divided into two groups on the basis of overall results. All subjects were followed for six months and then reassessed using the above-mentioned tests at the end of the study. From results obtained, it appears that Nimodipine is a useful tool for controlling the most common symptoms associated with mental deterioration in subjects affected by chronic cerebrovascular disorders.
为了评估尼莫地平对多形性病症（如慢性脑血管供血不足）的疗效，作者研究了96名年龄在65至85岁之间患有慢性脑血管疾病的受试者。使用测试分别评估各种症状，然后根据总体结果将受试者分为两组。所有受试者均接受了六个月的随访，并在研究结束时使用上述测试进行重新评估。从获得的结果来看，尼莫地平似乎是控制慢性脑血管疾病患者精神衰退相关最常见症状的有效药物。
